Inhibrx Biosciences Ownership | Who Owns Inhibrx Biosciences?


OverviewForecastRevenueFinancialsChart

Inhibrx Biosciences Ownership Summary


Inhibrx Biosciences is owned by 81.88% institutional investors, 23.16% insiders. Perceptive advisors is the largest institutional shareholder, holding 9.32% of INBX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Inhibrx Biosciences shares.

INBX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInhibrx Biosciences81.88%23.16%-5.04%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors1.44M9.32%$96.99M
Viking global investors lp1.44M9.28%$96.66M
Morgan stanley1.26M8.16%$84.92M
Sanofi1.16M7.48%$77.85M
Hightower advisors870.20K5.62%$58.50M
Blackrock funding, inc. /de798.90K5.16%$53.71M
Vanguard group623.08K4.03%$49.22M
State street550.85K3.56%$37.03M
Sofinnova investments406.03K2.62%$27.30M
Capital research global investors392.85K2.54%$26.41M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sanofi1.16M23.17%$77.85M
Perceptive advisors1.44M1.90%$96.99M
Pfm health sciences, lp305.43K1.87%$20.53M
Sofinnova investments406.03K1.04%$27.30M
Soleus capital management131.00K0.36%$8.81M
Summittx capital137.82K0.29%$9.27M
Viking global investors lp1.44M0.27%$96.66M
Readystate asset management lp170.16K0.24%$5.73M
Atom investors lp26.50K0.13%$1.78M
Schonfeld strategic advisors254.83K0.12%$17.13M

Top Buyers

HolderShares% AssetsChange
Woodline partners lp384.43K0.10%244.95K
State street550.85K0.00%175.88K
Readystate asset management lp170.16K0.24%143.32K
Norges bank133.30K0.00%133.30K
Soleus capital management131.00K0.36%106.00K

Top Sellers

HolderShares% AssetsChange
Blackrock---2.75M
Ra capital management---2.63M
Tcg crossover management---1.75M
Alpine associates management---1.05M
Bank of america corp /de/---741.59K

New Positions

HolderShares% AssetsChangeValue
Norges bank133.30K0.00%133.30K$10.53M
Vanguard fiduciary trust64.32K0.00%64.32K$4.32M
Exoduspoint capital management, lp30.98K0.02%30.98K$2.08M
Atom investors lp26.50K0.13%26.50K$1.78M
Centiva capital, lp17.74K0.01%17.74K$1.19M

Sold Out

HolderChange
Financial gravity asset management-2.00
Jones financial companies lllp-4.00
Ifp advisors-4.00
Rockefeller capital management-13.00
Lindbrook capital-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026143-7.74%12,680,697-0.76%811.20%76-10.59%34-15.00%
Dec 31, 202567-36.19%4,787,060-54.40%300.67%38-19.15%14-61.11%
Sep 30, 202540-54.02%3,943,558-62.21%250.56%11-64.52%14-58.82%
Jun 30, 202586-10.42%10,434,307-3.62%671.38%303.45%34-5.56%
Mar 31, 20259-91.59%2,655,100-76.21%180.35%2-95.74%2-93.55%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv369.64K2.53%5.80K
American Funds SMALLCAP World A353.29K2.42%-26.93K
State Street® SPDR® S&P® Biotech ETF327.43K2.24%-2.36K
iShares Russell 2000 ETF215.66K1.48%1.83K
Vanguard Institutional Extnd Mkt Idx Tr109.42K0.75%574.00
HBM Healthcare Investments AG Ord100.00K0.68%100.00K
Fidelity Small Cap Index88.68K0.61%855.00
iShares Russell 2000 Value ETF76.91K0.53%413.00
iShares Biotechnology ETF75.41K0.52%1.15K
Kennedy Micro Cap72.81K0.50%1.32K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 07, 2025VIKING GLOBAL INVESTORS LP-Sell$9.95M
Oct 07, 2025VIKING GLOBAL INVESTORS LP-Sell$526.16K
Oct 07, 2025VIKING GLOBAL INVESTORS LP-Sell$807.60K
Nov 20, 2024Kayyem Jon Faiz-Buy$266.10K
Nov 19, 2024Kayyem Jon Faiz-Buy$495.71K

Insider Transactions Trends


DateBuySell
2026 Q2--
2025 Q4-3
2025 Q2--
2025 Q1--
2024 Q43-

INBX Ownership FAQ


Who Owns Inhibrx Biosciences?

Inhibrx Biosciences shareholders are primarily institutional investors at 81.88%, followed by 23.16% insiders and -5.04% retail investors. The average institutional ownership in Inhibrx Biosciences's industry, Biotech Stocks , is 35.75%, which Inhibrx Biosciences exceeds.

Who owns the most shares of Inhibrx Biosciences?

Inhibrx Biosciences’s largest shareholders are Perceptive advisors (1.44M shares, 9.32%), Viking global investors lp (1.44M shares, 9.28%), and Morgan stanley (1.26M shares, 8.16%). Together, they hold 26.75% of Inhibrx Biosciences’s total shares outstanding.

Does Blackrock own Inhibrx Biosciences?

BlackRock is not among the top 10 institutional shareholders of Inhibrx Biosciences.

Who is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested?

Sanofi is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested, with 23.17% of its assets in 1.16M Inhibrx Biosciences shares, valued at 77.85M$.

Who is the top mutual fund holder of Inhibrx Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Inhibrx Biosciences shares, with 2.53% of its total shares outstanding invested in 369.64K Inhibrx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools